View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 27, 2011

Medicis Technologies LipoSonix system gets FDA clearance

Medicis Pharmaceutical's subsidiary Medicis Technologies has received US Food and Drug Administration (FDA) clearance for its second generation LipoSonix system, designed for non-invasive waist circumference reduction.

Medicis Pharmaceutical’s subsidiary Medicis Technologies has received US Food and Drug Administration (FDA) clearance for its second generation LipoSonix system, designed for non-invasive waist circumference reduction.

The LipoSonix system uses high-intensity focused ultrasound energy to disrupt subcutaneous adipose tissue.

The approval is backed by a multicentre, randomised, sham-controlled and blind study, which showed that treatment with the LipoSonix system was superior to a sham control in reducing waist circumference.

Clinical studies conducted by Medicis Technologies demonstrated an average waist circumference reduction of approximately 2.6cm after a single treatment with the LipoSonix system.

The first generation LipoSonix system is currently available in Canada, the European Union and Japan.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management